History of Vaccination

Last modified 4 weeks ago
Revisions 2 revisions

The history of vaccination spans over two centuries of scientific discovery, public health triumphs, and ongoing challenges. From Edward Jenner’s pioneering use of cowpox to protect against smallpox to modern mRNA vaccines, vaccination has saved more lives than any other medical intervention in history — estimated at over 154 million lives in the past 50 years alone. Vaccines work by training The Human Immune System to recognize and fight specific pathogens without causing disease.

Early Inoculation

Long before modern vaccines, various cultures practiced variolation — deliberately exposing people to material from mild smallpox cases to induce immunity. Chinese physicians used powdered smallpox scabs as early as the 10th century. Lady Mary Wortley Montagu introduced Ottoman variolation practices to Britain in 1721 after observing them in Constantinople, a city at the crossroads of trade routes connected to The Silk Road.

Variolation carried significant risk — about 2-3% of recipients died — but this was far lower than the 30% mortality rate of natural smallpox infection.

Jenner and the Birth of Vaccination

In 1796, English physician Edward Jenner observed that milkmaids who had contracted cowpox appeared immune to smallpox. He inoculated 8-year-old James Phipps with material from a cowpox lesion, then demonstrated that the boy was protected against smallpox. Jenner coined the term “vaccine” from vacca (Latin for cow) and published his findings in 1798.

Despite initial skepticism, vaccination spread rapidly. By 1801, over 100,000 people in Britain had been vaccinated. Napoleon had his entire army vaccinated, recognizing its strategic military value.

The Golden Age of Vaccines

Louis Pasteur expanded vaccination beyond smallpox in the 1880s, developing vaccines against anthrax and rabies and establishing the germ theory of disease. The late 19th and early 20th centuries saw vaccines developed for:

  • Cholera (1885) — The first laboratory-developed bacterial vaccine
  • Plague (1897) — Developed during epidemic outbreaks
  • Diphtheria (1923) — Using inactivated toxin (toxoid)
  • Tuberculosis (BCG, 1921) — Using attenuated bacteria
  • Yellow fever (1937) — A live attenuated vaccine still in use today

Polio and the Modern Era

The development of polio vaccines marked a watershed. Jonas Salk’s inactivated vaccine (1955) and Albert Sabin’s oral vaccine (1961) transformed polio from a feared epidemic disease to one on the verge of global eradication. The success of polio vaccination demonstrated that organized public health campaigns could eliminate diseases entirely.

The Expanded Programme on Immunization (1974) brought vaccines to developing nations, and global smallpox eradication was certified in 1980 — the first (and so far only) human disease deliberately eliminated.

mRNA Revolution

The COVID-19 pandemic accelerated a new vaccine technology: mRNA vaccines. Rather than using weakened or inactivated pathogens, mRNA vaccines deliver genetic instructions for cells to produce a harmless piece of the target virus, stimulating an immune response. Developed in record time by Pfizer-BioNTech and Moderna, these vaccines demonstrated over 90% efficacy and are now being adapted for influenza, RSV, HIV, and cancer.

The mRNA platform, combined with Artificial Intelligence for antigen design, promises faster responses to future pandemics and personalized cancer vaccines tailored to individual tumors.

Challenges

Despite extraordinary success, vaccination faces ongoing challenges: equitable global distribution, vaccine hesitancy fueled by misinformation, the need for cold-chain infrastructure in developing regions, and emerging pathogens that mutate rapidly. Continued research in Nutrition Science and immunology helps optimize vaccine efficacy across diverse populations.

Was this article helpful?

Know something we missed? Log in to edit this page.